Concepedia

Seong A. Kang

SA

Statistics

Publications

22

Citations

8.7K

H-Index

19

Active since

2004

Affiliations

Whitehead Institute for Biomedical Research(Current)

Massachusetts Institute of Technology

Howard Hughes Medical Institute

Harvard University

Dana-Farber Cancer Institute

Seong A. Kang is an author at Whitehead Institute for Biomedical Research specializing in mtor signaling, mtor inhibition, and mtor inhibitor therapy.

Publications per year

2004–2019

22

Publications

22

An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1

Carson C. Thoreen, Seong A. Kang, Jae Won Chang et al. · Journal of Biological Chemistry · 2009 · 1.8K citations · Full text

, , +14

PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase

Yasemin Sancak, Carson C. Thoreen, Timothy R. Peterson et al. · Molecular Cell · 2007 · 1.2K citations · Full text

, , +12

mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway

Timothy R. Peterson, Shomit Sengupta, Thurl E. Harris et al. · Cell · 2011 · 1.2K citations · Full text

, , +11

DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival

Timothy R. Peterson, Mathieu Laplante, Carson C. Thoreen et al. · Cell · 2009 · 1.2K citations · Full text

, , +14

The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling

Peggy P. Hsu, Seong A. Kang, Jonathan Rameseder et al. · Science · 2011 · 1.1K citations · Full text

, , +15

1–5 of 22